Show simple item record

Clinical, Biochemical, and Radiological Characteristics of the First Cluster of Covid‑19 Cases in Benghazi, Libya: Case Series

dc.date.accessioned2022-01-27T10:38:21Z
dc.date.available2022-01-27T10:38:21Z
dc.date.issued2020-09-01
dc.identifier.urihttp://repository.limu.edu.ly/handle/123456789/3560
dc.description.abstractThe 1st confirmed Covid‑19 case in Libya was reported from Tripoli on March 25, 2020. However, as of May 21, 2020, Libya has 69 confirmed cases, which is a very small number of cases in comparison to the rest of the world. This report describes the 1st cluster of confirmed Covid‑19 cases in Benghazi, Libya, which were discovered during the 7th and 8th of April 2020. The clinical, biological, and radiological characteristics of a cluster of four cases (primary case and three secondary cases) were described in this report. Among the four confirmed cases, two were asymptomatic, one symptomatic, and one presymptomatic. The transmission rate in this cluster was three, and the secondary attack rate among the household contacts was 37.5%. None of the four cases was severe and all of them recovered without complications. this preliminary experience is in concordance with the reports from the other parts of the worlden_US
dc.language.isoenen_US
dc.publisherwww.ljmsonline.comen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectCorona, COVID‑19, Libya, lymphopenia, severe acute respiratory syndrome coronavirus 2en_US
dc.titleClinical, Biochemical, and Radiological Characteristics of the First Cluster of Covid‑19 Cases in Benghazi, Libya: Case Seriesen_US
dc.title.alternativeClinical, Biochemical, and Radiological Characteristics of the First Cluster of Covid‑19 Cases in Benghazi, Libya: Case Seriesen_US
dc.typeOtheren_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States